Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment

被引:184
作者
Jorde, R
Waterloo, K
Storhaug, H
Nyrnes, A
Sundsfjord, J
Jenssen, TG
机构
[1] Univ Tromso, Inst Clin Med, N-9037 Tromso, Norway
[2] Univ Hosp N Norway, Dept Internal Med, N-9038 Tromso, Norway
[3] Univ Hosp N Norway, Dept Clin Chem, N-9038 Tromso, Norway
[4] Natl Hosp, Dept Nephrol, N-0027 Oslo, Norway
关键词
D O I
10.1210/jc.2005-1775
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Our objective was to examine the relation between neuropsychological function and subclinical hypothyroidism (SHT), defined as serum TSH of 3.5-10.0 mIU/liter and normal serum free T-4 and free T-3 levels, and to study the effect of T-4 supplementation. Subjects: A total of 89 subjects (45 males) with SHT and 154 control subjects (72 males) were recruited from a general health survey (the fifth Tromso study). Sixty-nine of those with SHT were included in a placebo-controlled, double-blind intervention study with T-4 medication for 1 yr. Main Outcome Measures: We used fourteen tests of cognitive function, Beck Depression Inventory, General Health Questionnaire, and a questionnaire on hypothyroid symptoms. Results: The mean +/- SD serum TSH in the SHT and control group were 5.57 +/- 1.68 and 1.79 +/- 0.69 mIU/liter, respectively. There were no significant differences in cognitive function and hypothyroid symptoms between the two groups, but those with SHT scored significantly better than the controls on the GHQ-30. At the end of the intervention study, serum TSH in the T-4 group (n=36) and the placebo group (n=33) were 1.52 +/- 1.51 and 5.42 +/- 1.96 mIU/liter, respectively. T-4 substitution had no effect on any of the parameters measured. Conclusion: In subjects with SHT where the serum TSH level is in the 3.5-10.0 mIU/liter range, there is no neuropsychological dysfunction, and compared with healthy controls, there is no difference in symptoms related to hypothyroidism.
引用
收藏
页码:145 / 153
页数:9
相关论文
共 42 条
[1]   When to treat mild hypothyroidism [J].
Ayala, AR ;
Danese, MD ;
Ladenson, PW .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2000, 29 (02) :399-+
[2]   Psychopathological and cognitive features in subclinical hypothyroidism [J].
Baldini, IM ;
Vita, A ;
Mauri, MC ;
Amodei, V ;
Carrisi, M ;
Bravin, S ;
Cantalamessa, L .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1997, 21 (06) :925-935
[3]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[4]   Theimportanceof using strict inclusion criteria in subclinical hypothyroid studies [J].
Biondi, B ;
Palmieri, EA ;
Lombardi, G ;
Fazio, S .
AMERICAN JOURNAL OF MEDICINE, 2003, 114 (01) :76-76
[5]   Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population.: The Health Study of Nord-Trondelag (HUNT) [J].
Bjoro, T ;
Holmen, J ;
Krüger, O ;
Midthjell, K ;
Hunstad, K ;
Schreiner, T ;
Sandnes, L ;
Brochmann, H .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (05) :639-647
[6]  
BONAA KH, 1992, CIRCULATION, V86, P394
[7]   Cognitive and affective status in mild hypothyroidism and interactions with L-thyroxine treatment [J].
Bono, G ;
Fancellu, R ;
Blandini, F ;
Santoro, G ;
Mauri, M .
ACTA NEUROLOGICA SCANDINAVICA, 2004, 110 (01) :59-66
[8]   The Colorado thyroid disease prevalence study [J].
Canaris, GJ ;
Manowitz, NR ;
Mayor, G ;
Ridgway, EC .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) :526-534
[9]   Do traditional symptoms of hypothyroidism correlate with biochemical disease? [J].
Canaris, GJ ;
Steiner, JF ;
Ridgway, EC .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1997, 12 (09) :544-550
[10]   The treatment of subclinical hypothyroidism is seldom necessary [J].
Chu, JW ;
Crapo, LM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) :4591-4599